The following is the full transcript of an interview with Dr. Peter Marks, former head of FDA's Center for Biologics ...

As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...

Right off the bat, the high-profile departure of Peter Marks, M.D., Ph.D., former director of the FDA’s Center for Biologics ...

Vaccine makers were hit particularly hard yesterday, as Marks’ resignation letter alluded to disagreements with HHS Secretary ...

In his resignation letter, Marks cited disagreement with HHS Secretary Robert F. Kennedy Jr., who he said pushed ...

Dr. Peter Marks speaks during a Senate hearing in 2021 in Washington, DC. Senior Correspondent Dr. Peter Marks is the kind of health official both Democrats and Republicans used to admire.

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

The stock market—and biotech insiders—reacted negatively to the allegedly forced resignation of CBER Director Peter Marks, ...

The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for ...

Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation ...

Peter Marks, the Food and Drug Administration (FDA) vaccine official who resigned last week amid pressure from the Trump administration, urged families to continue vaccinating their children.

On Friday, Dr. Peter Marks announced his resignation from the U.S. Food and Drug Administration (FDA) as Director of CEBR (Center for Biologics Evaluation and Research) citing differences with ...